Simplex Trading’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,300
Closed -$117K 11880
2021
Q4
$117K Buy
+4,300
New +$117K ﹤0.01% 6006
2021
Q2
Sell
-9
Closed -$18K 10991
2021
Q1
$18K Sell
9
-17
-65% -$392 ﹤0.01% 7563
2020
Q4
$59K Sell
26
-11
-30% -$209 ﹤0.01% 6016
2020
Q3
$60K Sell
37
-17
-31% -$308 ﹤0.01% 5441
2020
Q2
$73K Sell
54
-124
-70% -$1.44K ﹤0.01% 5139
2020
Q1
$210K Sell
178
-65
-27% -$1.44K ﹤0.01% 3533
2019
Q4
$605K Buy
243
+70
+40% +$1.42K ﹤0.01% 2562
2019
Q3
$294K Sell
173
-42
-20% -$764 ﹤0.01% 3188
2019
Q2
$489K Buy
215
+145
+207% +$3.91K ﹤0.01% 2582
2019
Q1
$225K Sell
70
-119
-63% -$3.68K ﹤0.01% 3479
2018
Q4
$532K Buy
189
+4
+2% +$117 ﹤0.01% 2168
2018
Q3
$531K Buy
185
+90
+95% +$2.7K ﹤0.01% 2570
2018
Q2
$355K Buy
95
+84
+764% +$3.3K ﹤0.01% 2821
2018
Q1
$3K Buy
+11
New +$402 ﹤0.01% 5110
2017
Q4
Sell
-9
Closed -$3K 6963
2017
Q3
$3K Sell
9
-287
-97% -$8.49K ﹤0.01% 4915
2017
Q2
$434K Buy
+296
New +$6.7K 0.02% 730

Other funds holding XENT

Simplex Trading's XENT Position: Q1 2022 in Review

Simplex Trading sold out of Intersect ENT, Inc (XENT) in Q1 2022, closing a stake of 7,862 shares — an estimated $214K sold.

Simplex Trading first reported a position in XENT in Q4 2016 and held it in 12 quarters. The position peaked at $511K in Q1 2021. 131 funds tracked by Wall St. Rank hold XENT as of Q1 2022.

  • Simplex Trading reported no remaining Intersect ENT, Inc position as of Q1 2022 after selling out during the quarter.
  • Simplex Trading sold 7,862 Intersect ENT, Inc shares in Q1 2022, an estimated $214K.
  • Simplex Trading first reported a position in Intersect ENT, Inc in Q4 2016 and held it in 12 quarters.
  • Simplex Trading's Intersect ENT, Inc position peaked at $511K in Q1 2021.
  • 131 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2022.

Based on Simplex Trading's 13F filing for Q1 2022, filed 2 May 2022.